Non-fiber extract of psyllium with anti-tumorigenic effects and method for identifying the same
View Patent ↗A composition comprising a non-fiber organic extract of psyllium which is anti-tumorigenic is described. The composition both restores gap junctional intercellular communication (GJIC) and inhibits anchorage independent growth of mammalian cells which have been transformed with the ras oncogene. The composition is a useful chemotherapy and chemopreventative agent. The composition was identified using a novel method for determining the anti-tumorigenic potential of a compound or composition.
1. A method for inhibiting a tumor in a patient, wherein the tumor contains cells that are incompetent for gap junctional intercellular communication (GJIC), said method comprising:
providing to the patient a composition, in conjunction with a chemotherapy drug, comprising a mixture containing a methanol or ethanol extract of psyllium seed husk of Plantago ovata , which is free of fiber of the psyllium and is optionally in a pharmaceutically acceptable carrier, in an amount and for a time sufficient to inhibit the tumor in conjunction with the chemotherapy drug.
2. The method of claim 1 wherein the cells comprise a ras mutation.
3. The method of claim 1 wherein the psyllium seed husk is in the form of a powder.
4. The method of claim 1 wherein the mixture in vitro restores gap junctional intercellular communication and inhibits anchorage independent growth in mammalian cells containing a mutated ras gene and displaying unregulated proliferation.
5. The method of claim 1 wherein the patient is a human or a mammal.
6. A method for inhibiting a tumor in a patient, wherein the tumor contains cells that are incompetent for gap junctional intercellular communication (GJIC), said method comprising:
(a) providing to the patient in conjunction with a chemotherapy drug, a non-fiber component of psyllium produced by mixing psyllium seed husk with methanol or ethanol as a solvent so as to solubiize the non-fiber component of the psyllium seed husk and separating the solvent soluble, non-fiber component from the fiber component of the psyllium to produce the non-fiber component of psyllium which is free of the fiber component; and
(b) administering the non-fiber component of psyllium to the patient in an amount along with the chemotherapy drug for a time sufficient to inhibit the tumor.
7. The method of claim 6 wherein cells comprise a ras mutation.
8. A method of claim 6 wherein the non-fiber component is mixed with a pharmaceutically acceptable carrier.
9. The method of claim 3 wherein the psyllium seed husk is in the form of a powder.
10. The method of claim 6 wherein the non-fiber component in vitro restores gap junctional intercellular communication and inhibits anchorage independent growth in mammalian cells containing a mutated ras gene and displaying unregulated proliferation.
11. The method of claim 6 wherein the patient is a human or a mammal.